SAIMSARA Journal

Machine Generated Science • ISSN 3054-3991

Endovascular Management of Hemodialysis Arteriovenous Fistula: Scoping Review with ☸️SAIMSARA.

Cardiac & Vascular Health icon

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

DOI: 10.62487/saimsaraf23bb028

Editorial note
• Last update: 2026-05-14 20:45:23
What is this paper about
Endovascular hemodialysis AVF care is no longer only a rescue technique: the mapped evidence shows a full access-life-cycle strategy, from percutaneous creation and assisted maturation to repeated salvage of stenosed, immature, or thrombosed fistulas. The full SAIMSARA evidence map gives a structured, reference-linked view of which techniques work, where patency fails, how often reintervention is needed, and which patient or lesion phenotypes may benefit most.
Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.


Abstract: To map and synthesize studies evaluating endovascular creation, maintenance, salvage, complication management, imaging support, procedural access routes, analgesia, and comparative outcomes for hemodialysis AVFs. The review uses 133 references and builds its evidence map from 167 original studies with 171348 total participants (topic-deduplicated ΣN). The mapped evidence supports a role for endovascular management as a feasible, repeatable, and increasingly central strategy across the hemodialysis fistula life cycle, spanning percutaneous creation, assisted maturation, and salvage of stenosed or thrombosed access. Technical success was consistently high across endoAVF creation platforms, with 24-month cumulative patency reaching 91.7% in a multicenter WavelinQ cohort, while salvage of immature and thrombosed fistulas achieved technical success of 93%–97%. The literature indicates that durable access often depends on accepting repeated interventions rather than treating reintervention as failure, and that outcomes are strongly modulated by lesion location, anatomy, and timing. Heterogeneous designs, retrospective predominance, and inconsistent patency definitions limit certainty about comparative device superiority. Future randomized comparative trials using harmonized maturation, patency, and reintervention endpoints are needed to clarify which endovascular strategies provide the most durable, cost-effective access for specific patient and lesion phenotypes.

Keywords: Endovascular arteriovenous fistula; Hemodialysis access; Percutaneous fistula creation; Balloon angioplasty; Fistula maturation; Primary patency; Vascular access dysfunction; Fistula salvage; Thrombosed fistula; Radiofrequency anastomosis

Review Stats

Get access to the full paper

Unlock the full evidence map

The full evidence review, including the Introduction, Methods, Results, Discussion, Conclusion, figures, and complete reference index, opens after purchase or sign-in. The Evidence Object JSON is a separate machine-readable evidence product: a concentrated synthesis of results, topic-level evidence, and discussion across original and non-original studies. It can be directly input into your LLM, agent, or RAG workflow.

Reference Index (133)